A new biosensor can detect bird flu in five minutes

Bird flu is an airborne virus that spreads between birds and other animals. Outbreaks on poultry and dairy farms are devastating; mass culling of exposed animals can be the only way to stem outbreaks. Some bird flu strains have also infected humans, though this is rare. As of early March, there had been 70 human cases and one confirmed death in the US, according to the Centers for Disease Control and Prevention.

The most common way to detect bird flu involves swabbing potentially contaminated sites and sequencing the DNA that’s been collected, a process that can take up to 48 hours.

The new device samples the air in real time, running the samples past a specialized biosensor every five minutes. The sensor has strands of genetic material called aptamers that were used to bind specifically to the virus. When that happens, it creates a detectable electrical change. The research, published in ACS Sensors in February, may help farmers contain future outbreaks.

Part of the group’s work was devising a way to deliver airborne virus particles to the sensor. 

With bird flu, says Rajan Chakrabarty, a professor of energy, environmental, and chemical engineering at Washington University and lead author of the paper, “the bad apple is surrounded by a million or a billion good apples.” He adds, “The challenge was to take an airborne pathogen and get it into a liquid form to sample.”

The team accomplished this by designing a microwave-­size box that sucks in large volumes of air and spins it in a cyclone-like motion so that particles stick to liquid-coated walls. The process seamlessly produces a liquid drip that is pumped to the highly sensitive biosensor. 

Though the system is promising, its effectiveness in real-world conditions remains uncertain, says Sungjun Park, an associate professor of electrical and computer engineering at Ajou University in South Korea, who was not involved in the study. Dirt and other particles in farm air could hinder its performance. “The study does not extensively discuss the device’s performance in complex real-world air samples,” Park says. 

But Chakrabarty is optimistic that it will be commercially viable after further testing and is already working with a biotech company to scale it up. He hopes to develop a biosensor chip that detects multiple pathogens at once. 

Carly Kay is a science writer based in Santa Cruz, California.